Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$180,407,389
New position
Shares Held
914,752
first reported quarter
Ownership
0.059%
of shares outstanding
% of Portfolio
3.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 91.14393846638215.ToString("F0")%
Shared 0.ToString("F0")%
None 8.856061533617856.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CAPITAL INTERNATIONAL SARL holds $415,680,689 across 10 Drug Manufacturers - General names. AZN ranks #1 (43.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
914,752 | $180,407,389 | |
| 2 | LLY |
ELI LILLY & Co
|
150,461 | $138,389,513 | |
| 3 | AMGN |
Amgen Inc
|
94,516 | $33,255,454 | |
| 4 | ABBV |
AbbVie Inc.
|
108,363 | $23,567,868 | |
| 5 | PFE |
Pfizer Inc
|
759,368 | $21,323,053 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
94,231 | $5,715,110 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
40,000 | $5,574,800 | |
| 8 | GRFS |
Grifols SA
|
645,251 | $5,174,913 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $180,407,389 | 914,752 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||